Siri Sebastián Omar, Martino Julieta, Gottifredi Vanesa
Cell Cycle and Genome Stability Laboratory, Fundación Instituto Leloir, C1405 BWE Buenos Aires, Argentina.
Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), C1405 BWE Buenos Aires, Argentina.
Cancers (Basel). 2021 Jun 19;13(12):3056. doi: 10.3390/cancers13123056.
Chromosomal instability (CIN) refers to an increased rate of acquisition of numerical and structural changes in chromosomes and is considered an enabling characteristic of tumors. Given its role as a facilitator of genomic changes, CIN is increasingly being considered as a possible therapeutic target, raising the question of which variables may convert CIN into an ally instead of an enemy during cancer treatment. This review discusses the origins of structural chromosome abnormalities and the cellular mechanisms that prevent and resolve them, as well as how different CIN phenotypes relate to each other. We discuss the possible fates of cells containing structural CIN, focusing on how a few cell duplication cycles suffice to induce profound CIN-mediated genome alterations. Because such alterations can promote tumor adaptation to treatment, we discuss currently proposed strategies to either avoid CIN or enhance CIN to a level that is no longer compatible with cell survival.
染色体不稳定(CIN)是指染色体获得数量和结构变化的速率增加,被认为是肿瘤的一个促成特征。鉴于其作为基因组变化促进因素的作用,CIN越来越被视为一个可能的治疗靶点,这就引发了一个问题:在癌症治疗期间,哪些变量可能使CIN从敌人转变为盟友。本综述讨论了结构性染色体异常的起源以及预防和解决这些异常的细胞机制,以及不同的CIN表型如何相互关联。我们讨论了含有结构性CIN的细胞的可能命运,重点关注几个细胞复制周期如何足以诱导由CIN介导的深刻基因组改变。由于这种改变可促进肿瘤对治疗的适应,我们讨论了目前提出的避免CIN或将CIN增强到不再与细胞存活相容水平的策略。